Literature DB >> 25531565

Low doses of CMV induce autoimmune-mediated and inflammatory responses in bile duct epithelia of regulatory T cell-depleted neonatal mice.

Jie Wen1, Yongtao Xiao1, Jun Wang2, Weihua Pan2, Ying Zhou2, Xiaoling Zhang3, Wenbin Guan4, Yingwei Chen5, Kejun Zhou5, Yang Wang5, Bisheng Shi3, Xiaohui Zhou3, Zhenghong Yuan3, Wei Cai1.   

Abstract

Recent studies have indicated that perinatal infection with cytomegalovirus (CMV) may promote bile duct damage in biliary atresia (BA) and that the decreased regulatory T cell (Treg) percentage associated with BA may further amplify the bile duct damage. Although a majority of BA patients have had previous CMV infections and lower percentages of Tregs, it is unknown whether an initial exposure to a low dose of CMV could induce exaggerated and progressive biliary injury. A Treg-depleted neonatal mouse was infected with low-dose CMV (LD-CMV) as a model to study BA patients. LD-CMV infection in Treg-depleted mice induced extensive inflammation in both the intrahepatic and extrahepatic bile ducts, accompanied with injury to and atresia of intrahepatic bile ducts and partial obstruction of the extrahepatic bile ducts. Serum total and direct bilirubin amounts were also elevated. Evidence for the involvement of cellular and humoral autoimmune responses in LD-CMV-infection of Treg-depleted mice was also obtained through detection of increased percentages of CD3 and CD8 mononuclear cells and serum autoantibodies reactive to bile duct epithelial proteins, one of which was identified as α-enolase. Depletion of Tregs that can lead to the decreased inhibition of aberrantly activated hepatic T-lymphocytes and generation of autoantibodies may lead to further injury. Increased hepatic expression of Th1-related genes (TNF-α), IFN-γ-activated genes (STAT-1) and Th1 cytokines (TNF-α, lymphotactin, IL-12p40 and MIP -1γ) were also identified. In conclusion, autoimmune-mediated and inflammatory responses induced by LD-CMV infection in Treg-depleted mice results in increased intrahepatic and extrahepatic bile duct injury and contributed to disease progression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25531565     DOI: 10.1038/labinvest.2014.148

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  36 in total

1.  Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease.

Authors:  Rebecca S McHugh; Ethan M Shevach
Journal:  J Immunol       Date:  2002-06-15       Impact factor: 5.422

2.  Post-natal paucity of regulatory T cells and control of NK cell activation in experimental biliary atresia.

Authors:  Alexander G Miethke; Vijay Saxena; Pranavkumar Shivakumar; Gregg E Sabla; Julia Simmons; Claire A Chougnet
Journal:  J Hepatol       Date:  2010-03-05       Impact factor: 25.083

3.  Cellular and humoral autoimmunity directed at bile duct epithelia in murine biliary atresia.

Authors:  Cara L Mack; Rebecca M Tucker; Brandy R Lu; Ronald J Sokol; Andrew P Fontenot; Yoshiyuki Ueno; Ronald G Gill
Journal:  Hepatology       Date:  2006-11       Impact factor: 17.425

4.  Cytomegalovirus-specific T-cell reactivity in biliary atresia at the time of diagnosis is associated with deficits in regulatory T cells.

Authors:  Stephen M Brindley; Allison M Lanham; Frederick M Karrer; Rebecca M Tucker; Andrew P Fontenot; Cara L Mack
Journal:  Hepatology       Date:  2012-04       Impact factor: 17.425

5.  Genetics, immunology, and biliary atresia: an opening or a diversion?

Authors:  R A Schreiber; R E Kleinman
Journal:  J Pediatr Gastroenterol Nutr       Date:  1993-02       Impact factor: 2.839

6.  [An experimental study of rat infected with human cytomegalovirus AD169 strain].

Authors:  H Meng; D Sun; J Wang
Journal:  Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi       Date:  2000-09

7.  Is there any association of extra hepatic biliary atresia with cytomegalovirus or other infections?

Authors:  Ghous Bukhsh Soomro; Zaigham Abbas; Mujahid Hassan; Nasir Luck; Yousuf Memon; Abdaal Wasim Khan
Journal:  J Pak Med Assoc       Date:  2011-03       Impact factor: 0.781

8.  Identification of an autoantibody against alpha-enolase in primary biliary cirrhosis.

Authors:  N Akisawa; T Maeda; S Iwasaki; S Onishi
Journal:  J Hepatol       Date:  1997-04       Impact factor: 25.083

9.  Foxp3 programs the development and function of CD4+CD25+ regulatory T cells.

Authors:  Jason D Fontenot; Marc A Gavin; Alexander Y Rudensky
Journal:  Nat Immunol       Date:  2003-03-03       Impact factor: 25.606

10.  Regulatory T cells inhibit Th1 cell-mediated bile duct injury in murine biliary atresia.

Authors:  Rebecca M Tucker; Amy G Feldman; Erika K Fenner; Cara L Mack
Journal:  J Hepatol       Date:  2013-05-14       Impact factor: 25.083

View more
  5 in total

Review 1.  Innate Immunity and Pathogenesis of Biliary Atresia.

Authors:  Ana Ortiz-Perez; Bryan Donnelly; Haley Temple; Greg Tiao; Ruchi Bansal; Sujit Kumar Mohanty
Journal:  Front Immunol       Date:  2020-02-25       Impact factor: 7.561

2.  Hepatic interferon γ and tumor necrosis factor a expression in infants with neonatal cholestasis and cytomegalovirus infection.

Authors:  Himali Meshram; Shilpa Velhal; Varsha Padwal; Jyoti Sutar; Ravi Kadam; Jacinta Pereira; Gauri Bhonde; Kalyani Karandikar; Vikrant Bhor; Vainav Patel; Naman S Shetty; Ira Shah
Journal:  Clin Exp Hepatol       Date:  2020-12-30

Review 3.  Human Cytomegalovirus and Autoimmune Diseases: Where Are We?

Authors:  Francesca Gugliesi; Selina Pasquero; Gloria Griffante; Sara Scutera; Camilla Albano; Sergio Fernando Castillo Pacheco; Giuseppe Riva; Valentina Dell'Oste; Matteo Biolatti
Journal:  Viruses       Date:  2021-02-08       Impact factor: 5.048

4.  Autoimmune liver disease-related autoantibodies in patients with biliary atresia.

Authors:  Shu-Yin Pang; Yu-Mei Dai; Rui-Zhong Zhang; Yi-Hao Chen; Xiao-Fang Peng; Jie Fu; Zheng-Rong Chen; Yun-Feng Liu; Li-Yuan Yang; Zhe Wen; Jia-Kang Yu; Hai-Ying Liu
Journal:  World J Gastroenterol       Date:  2018-01-21       Impact factor: 5.742

5.  A case of an infant with congenital combined pituitary hormone deficiency and normalized liver histology of infantile cholestasis after hormone replacement therapy.

Authors:  Keisuke Wada; Hironori Kobayashi; Aisa Moriyama; Yasuhiro Haneda; Yuichi Mushimoto; Yuki Hasegawa; Kazumichi Onigata; Koji Kumori; Noriyoshi Ishikawa; Riruke Maruyama; Tsuyoshi Sogo; Lynne Murphy; Takeshi Taketani
Journal:  Clin Pediatr Endocrinol       Date:  2017-09-28
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.